Cargando…

Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

BACKGROUND: Fatty acid (FA) metabolism is considered the emerging cause of tumor development and metastasis, driving poor prognosis. Long non-coding RNAs (lncRNAs) are closely related to cancer progression and play important roles in FA metabolism. Thus, the discovery of FA metabolism-related lncRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Erbao, Yi, Jing, Jiang, Jing, Zou, Zhilin, Mo, Yuqian, Ren, Qingqi, Lin, Zewei, Lu, Yi, Zhang, Jian, Liu, Jikui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531484/ https://www.ncbi.nlm.nih.gov/pubmed/36195833 http://dx.doi.org/10.1186/s12885-022-10122-4

Ejemplares similares

A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy
por: Chen, Erbao, et al.
Publicado: (2023)

CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway
por: Chen, Erbao, et al.
Publicado: (2023)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Overexpression of SRD5A3 in Hepatocellular Carcinoma and Its Molecular Mechanism: A Study of Bioinformatics Exploration Analysis with Experimental Verification
por: Chen, Erbao, et al.
Publicado: (2022)

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
por: Bai, Zhixun, et al.
Publicado: (2022)

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021)

lncRNA DQ786243 promotes hepatocellular carcinoma cell invasion and proliferation by regulating the miR-15b-5p/Wnt3A axis
por: Lin, Zewei, et al.
Publicado: (2022)

Identification and Characterization of an Ageing-Associated 13-lncRNA Signature That Predicts Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Li, Fulei, et al.
Publicado: (2023)

Development of a novel angiogenesis-related lncRNA signature to predict the prognosis and immunotherapy of glioblastoma multiforme
por: Zhang, Binbin, et al.
Publicado: (2022)

Identification and Application of a Novel Immune-Related lncRNA Signature on the Prognosis and Immunotherapy for Lung Adenocarcinoma
por: Zeng, Zhimin, et al.
Publicado: (2022)

Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
por: Lin, Kefan, et al.
Publicado: (2023)

Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
por: Yang, Lihong, et al.
Publicado: (2023)

lncRNA Gene Signatures for Prediction of Breast Cancer Intrinsic Subtypes and Prognosis
por: Zhang, Silu, et al.
Publicado: (2018)

A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma
por: Zheng, Yinfei, et al.
Publicado: (2022)

A new acidic microenvironment related lncRNA signature predicts the prognosis of liver cancer patients
por: Jiang, Peng, et al.
Publicado: (2022)

A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients
por: Peng, Jing, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
por: Cheng, Meng, et al.
Publicado: (2021)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023)

Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma
por: Zhang, Hongpan, et al.
Publicado: (2022)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
por: Huang, Qian-Rong, et al.
Publicado: (2022)

lncRNAs as potential molecular biomarkers in the clinicopathology and prognosis of cholangiocarcinoma: a systematic review and meta-analysis
por: Dai, Kangfu, et al.
Publicado: (2019)

Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature
por: Hu, Chuling, et al.
Publicado: (2022)

Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
por: Zhang, Ze, et al.
Publicado: (2022)

Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma
por: Zheng, Ze-Jun, et al.
Publicado: (2022)

Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis
por: Li, Hanrong, et al.
Publicado: (2023)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
por: Pang, Lin, et al.
Publicado: (2023)

LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy
por: Li, Gaopeng, et al.
Publicado: (2021)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

Identification of a apoptosis-related LncRNA signature to improve prognosis prediction and immunotherapy response in lung adenocarcinoma patients
por: Luo, Ting, et al.
Publicado: (2022)

LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
por: Huang, Rui, et al.
Publicado: (2020)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_47iadc7613s5sc2mb15rvmp5al